CAMBRIDGE, Mass. (AP) -- Infinity Pharmaceuticals Inc. said Monday that Adelene Perkins, its president and chief business officer, will become CEO on Jan. 1.
The company said Perkins will succeed founder, chairman and CEO Steven Holtzman. Holtzman, 55, started Infinity in 2001 and Perkins has been with the company since 2002. Perkins will join the board of directors, and Holtzman will remain with the company as executive chairman of the board.
Perkins became president of the company in October 2008.
